1. Home
  2. ASMB vs IH Comparison

ASMB vs IH Comparison

Compare ASMB & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • IH
  • Stock Information
  • Founded
  • ASMB 2005
  • IH 1996
  • Country
  • ASMB United States
  • IH China
  • Employees
  • ASMB N/A
  • IH N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • IH Other Consumer Services
  • Sector
  • ASMB Health Care
  • IH Real Estate
  • Exchange
  • ASMB Nasdaq
  • IH Nasdaq
  • Market Cap
  • ASMB 139.8M
  • IH 123.1M
  • IPO Year
  • ASMB 2010
  • IH 2020
  • Fundamental
  • Price
  • ASMB $18.75
  • IH $2.28
  • Analyst Decision
  • ASMB Strong Buy
  • IH
  • Analyst Count
  • ASMB 3
  • IH 0
  • Target Price
  • ASMB $33.00
  • IH N/A
  • AVG Volume (30 Days)
  • ASMB 43.5K
  • IH 19.6K
  • Earning Date
  • ASMB 08-07-2025
  • IH 06-26-2025
  • Dividend Yield
  • ASMB N/A
  • IH 3.71%
  • EPS Growth
  • ASMB N/A
  • IH N/A
  • EPS
  • ASMB N/A
  • IH 0.26
  • Revenue
  • ASMB $32,154,000.00
  • IH $123,701,096.00
  • Revenue This Year
  • ASMB $0.04
  • IH $39.02
  • Revenue Next Year
  • ASMB N/A
  • IH N/A
  • P/E Ratio
  • ASMB N/A
  • IH $8.74
  • Revenue Growth
  • ASMB 148.33
  • IH N/A
  • 52 Week Low
  • ASMB $7.75
  • IH $1.47
  • 52 Week High
  • ASMB $19.93
  • IH $3.18
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 65.84
  • IH 43.26
  • Support Level
  • ASMB $18.01
  • IH $2.20
  • Resistance Level
  • ASMB $18.99
  • IH $2.70
  • Average True Range (ATR)
  • ASMB 0.84
  • IH 0.13
  • MACD
  • ASMB -0.05
  • IH -0.02
  • Stochastic Oscillator
  • ASMB 84.42
  • IH 14.42

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

Share on Social Networks: